Sue Harnan
Population Health, School of Medicine and Population Health
Senior Research Fellow
+44 114 222 0869
Full contact details
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
91̽»¨
S1 4DA
- Profile
-
I graduated from the University of 91̽»¨ in 1996 with a BSc in Physiology and went on to graduate with an MSc in Science, Culture and Communication at the University of Bath in 2002. I worked in the charitable sector as a systematic reviewer at Penny Brohn Cancer Care for two years before joining ScHARR in 2009.
My primary interest is in Health Technology Assessment, and I have been a member of ScHARR’s Technology Assessment Group (ScHARR-TAG), which conducts assessments for the National Institute for Health and Care Excellence (NICE), since 2009. I have worked on and led systematic reviews and technology appraisals on a wide range of topics as part of this programme of work, and have special interest and expertise in diagnostic and prognostic topics.
I also plan and conduct reviews as part of ScHARR’s Knowledge Exchange partnerships, with industry, public health and charitable funders.
- Research interests
-
- Health technology assessment
- Systematic review methodologies including
- Diagnostic reviews
- Rapid reviews
- Review of reviews
- Review techniques for network meta analyses
- Non-RCT reviews
- Systematic review of psychometric properties of outcome measures
- Health and wellbeing benefits of the natural environment
Recent and current projects
Recent and current NICE projects
- Quantitative faecal immunochemical tests to guide referral in primary care for people with a change in bowel habit or abdominal pain [DAP50] (Diagnostic Assessment Report for NICE) (2020- ongoing; project lead)
- Volanesorsen for treating familial chylomicronaemia syndrome [ID1326] (Highly Specialised Technology assessment for NICE) (2018-19; project lead)
- Velmanase alfa for treating alpha-mannosidosis [ID800] (Highly Specialised Technology Assessment for NICE) (2018-19) Trifluridine–tipiracil for treating metastatic gastric or gastro-oesophageal junction cancer after 2 or more therapies [ID1507](Single Technology Appraisal for NICE) (2019)
- Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis (Diagnostic Assessment for NICE) (2017-18; project lead)
Recent and current other work
- The impact of pruritus on health-related quality of life (HRQoL) in patients with end-stage kidney disease (ESKD) or chronic kidney disease associated with pruritus (CKD-aP) on haemodialysis: a systematic review (Commercial sponsor) (2020 – ongoing)
- A series of systematic reviews and meta-analyses of the risk of hip and non-vertebral fractures in patients with chronic kidney disease, Parkinson’s disease and diabetes (Commercial Sponsor) (2019)
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- . Bone, 132.
- . Health Technology Assessment, 23(30).
- . Clinical and Experimental Allergy, 47(3), 410-429.
- . PharmacoEconomics, 35(1), 97-109.
- . PharmacoEconomics, 34(12), 1241-1253.
- . EBioMedicine.
- . Acta Haematologica, 136(1), 23-42.
- . Evidence & Policy: A Journal of Research, Debate and Practice, 11(4), 589-601.
- . British Journal of Surgery, 99(12), 1630-1638.
- . Health Technology Assessment, 15(40).
- . Eur J Surg Oncol, 37(11), 928-936.
- . J Trauma, 71(1), 245-251.
- . Eur J Surg Oncol, 37(3), 187-198.
- . Archives of Disease in Childhood, 96(5), 414-421.
- . Health Technology Assessment, 19(82), 1-330.
Conference proceedings papers
All publications
Journal articles
- . Applied Health Economics and Health Policy, 1-13.
- . Comprehensive Psychoneuroendocrinology.
- . JAC-Antimicrobial Resistance, 5(1).
- . Value in Health, 25(5), 761-769.
- . Clinical Kidney Journal, 15(3), 484-499.
- . Bone, 137.
- . American Journal of Kidney Diseases.
- . Bone, 132.
- . Health Technology Assessment, 23(30).
- . Applied Health Economics and Health Policy, 17(3), 295-313.
- . PharmacoEconomics, 36(10), 1143-1151.
- . BMJ Open, 8(2), e018132-e018132.
- . BMC Cancer, 17, 697-697.
- . Pharmacoeconomics.
- . Clinical and Experimental Allergy, 47(3), 410-429.
- . PharmacoEconomics, 35(1), 97-109.
- . PharmacoEconomics, 34(12), 1241-1253.
- . EBioMedicine.
- . Acta Haematologica, 136(1), 23-42.
- . Pediatric Pulmonology, 51(3), 316-328.
- . European Respiratory Society, 47(3), 751-768.
- . Journal of Health Services Research & Policy, 21(1), 51-60.
- . Evidence & Policy: A Journal of Research, Debate and Practice, 11(4), 589-601.
- . Journal of Trauma and Acute Care Surgery, 78(1), 164-177.
- . Cancer Causes Control, 25(6), 647-658.
- . Angiology, 65(3), 190-197.
- . PHARMACOECONOMICS, 32(2), 159-172.
- . Health Technol Assess, 17(56), v-181.
- . Eur Respir Rev, 22(130), 476-486.
- . Br J Surg, 100(13), 1838-1839.
- . Health Technol Assess, 17(44), 1-302.
- . British Journal of Surgery, 99(12), 1630-1638.
- . J Neurotrauma, 29(5), 707-718.
- . Health Technology Assessment, 15(40).
- . Eur J Surg Oncol, 37(11), 928-936.
- . Journal of Paramedic Practice, 3(8), 418-423.
- . Health Technol Assess, 15(27), 1-202.
- . J Trauma, 71(1), 245-251.
- . Eur J Surg Oncol, 37(3), 187-198.
- . Health Technol Assess, 15(4), iii-134.
- . Archives of Disease in Childhood, 96(5), 414-421.
- . Eur J Surg Oncol, 37(1), 40-46.
- Faecal Immunochemical Tests For Patients With Symptoms Suggestive Of Colorectal Cancer: An Updated Systematic Review And Multiple-Threshold Meta-Analysis of Diagnostic Test Accuracy Studies. Colorectal Disease.
- . Health Technology Assessment, 1-230.
- . International Journal of Neonatal Screening, 10(3), 56-56.
- . International Journal of Neonatal Screening, 10(3), 49-49.
- . Health Technology Assessment, 1-238.
- . Health Technology Assessment, 19(82), 1-330.
Conference proceedings papers
- . Journal of the Endocrine Society, Vol. 4(Supplement_1). San Francisco, CA, USA, 28 March 2020 - 31 March 2020.
- THE RISK OF HIP AND NON-VERTEBRAL FRACTURES IN PARKINSON'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. OSTEOPOROSIS INTERNATIONAL, Vol. 31(SUPPL 1) (pp S55-S55)
- The Risk of Hip and Non-Vertebral Fractures in Parkinson's Disease: A Systematic Review and Meta-Analysis. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 103-103)
- The Risk of Hip and Non-Vertebral Fractures in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 34 (pp 25-25)
- . Value in Health, Vol. 18(7) (pp A345-A345)
- . Blood, Vol. 124(21) (pp 1934-1934)
- . Value in Health, Vol. 16(7) (pp A372-A372)
- . VALUE IN HEALTH, Vol. 16(7) (pp A367-A367)
- . VALUE IN HEALTH, Vol. 15(7) (pp A633-A633)
- . VALUE IN HEALTH, Vol. 14(7) (pp A245-A245)
- . VALUE IN HEALTH, Vol. 14(7) (pp A244-A244)
- . VALUE IN HEALTH, Vol. 14(7) (pp A343-A343)
- . VALUE IN HEALTH, Vol. 14(7) (pp A244-A244)
- alpha(1B)-adrenoceptor affinity and density differentiated and undifferentiated mouse glomerular mesangial cells.. J AM SOC NEPHROL, Vol. 8 (pp A1432-A1432)
- EFFECTS OF LY293558 AND NBQX ON GLUTAMATE-RECEPTOR RESPONSES IN RAT CEREBELLAR PURKINJE NEURONS AND HEK293 CELLS EXPRESSING THE HUMAN GLUR6 GLUTAMATE-RECEPTOR. BRIT J PHARMACOL, Vol. 115 (pp P112-P112)
Reports
- Newborn screening for congenital adrenal hyperplasia. External review against programme appraisal criteria for the UK National Screening Committee
- Final report for the technology evaluation of ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections.
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix J - Dementia.
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix K - Cardiovascular.
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix H - Psychological Therapies
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix I - Schizophrenia
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix E - Diabetes
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix G - Head and Neck Cancer.
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy
- . Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer.
- Supporting the collection patient reported outcome measures in the National Clinical Audits for assessing costeffectiveness Work Package 1. What patient reported outcome measures should be used in the 13 health conditions specified in the 2013/14 National Clinical Audit programme? APPENDIX C, INFLAMMATORY BOWEL DISEASE
- Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme.
Posters
- Clinical Decision Rules for children with minor head injury: A systematic review. European Society of Emergency Medicine,(EuSEM) Stockholm.
- Diagnostic accuracy of individual characteristics following minor head injury in children: A systematic review.
- A systematic review of Clinical Decision Rules in the management of adult minor head injury.
- Surgical interventions for the primary prophylaxis of retinal detachment in Stickler Syndrome: a systematic review.
- Magnetic resonance imaging (MRI) for assessment of axillary lymph node metastases in breast cancer: systematic review.
- Clinical decision rules for adults with minor head injury: a systematic review.
- Towards cost-effectiveness analysis of the health and wellbeing benefits of urban green space: a mapping review.
- The role of biochemical markers in the identification of intracranial pathology following minor head injury: a systematic review and meta-analysis.
- Diagnostic accuracy of clinical characteristics following minor head injury: a systematic review and meta-analysis.
- Clinical Decision Rules for children with minor head injury: A systematic review.
- Exhaled nitric oxide for the diagnosis of asthma in children and adults: a systematic review.
- Diagnostic accuracy of clinical characteristics following minor head injury: a systematic review and meta-analysis.
- Teaching interests
-
I am a module co-ordinator for HAR6501, Systematic Reviews and Critical Appraisal Techniques on ScHARR’s Masters in Public Health. I also teach on ScHARR’s short courses and bespoke training courses, including our Systematic Review short course, our Rapid Review short course and our short course on Reviewing for Modelling Parameters.